PEN

Photon Energy NV
$321.23-$0.11-0.04%Price as of Nov 3, 2026, 9:34 AM ET

Key stats

Market cap
12.7B
Open
—
Day range
—
52-week range
$225.52 – $362.41
Volume
6.06K
Avg volume
407K

Earnings

Q3 FY26Miss
Expected$1.24
Actual$1.07
Q2 FY26
Actual$0.88
Q1 FY26
Actual$0.82
Q4 FY25
Actual$1.20

Next earnings call Nov 20, 2026

About

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Employees
4,700
Headquarters
Alameda, CA